Cytokinetics
CYTK
#2440
Rank
S$9.79 B
Marketcap
S$80.11
Share price
1.64%
Change (1 day)
39.86%
Change (1 year)

Earnings for Cytokinetics (CYTK)

Earnings in 2025 (TTM): -S$0.99 Billion

According to Cytokinetics 's latest financial reports the company's current earnings are S$87.21 Million. In 2024 the company made an earning of -S$0.75 Billion a decrease over its 2023 earnings that were of -S$0.67 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytokinetics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.99 Billion32.34%
2024 -S$0.75 Billion12.03%
2023 -S$0.67 Billion35.3%
2022 -S$0.5 Billion80.65%
2021 -S$0.28 Billion69.15%
2020 -S$0.17 Billion4.6%
2019 -S$0.16 Billion14.49%
2018 -S$0.14 Billion-16.83%
2017 -S$0.17 Billion-812.8%
2016 S$22.66 M-147.81%
2015 -S$47.42 Million156.05%
2014 -S$18.52 Million-56.56%
2013 -S$42.64 Million-16.48%
2012 -S$51.05 Million-15.65%
2011 -S$60.52 Million-3.24%
2010 -S$62.55 Million-308.68%
2009 S$29.97 M-141.87%
2008 -S$71.58 Million0.21%
2007 -S$71.43 Million-7.91%
2006 -S$77.56 Million37.42%
2005 -S$56.44 Million16.13%
2004 -S$48.6 Million-19.29%
2003 -S$60.21 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
S$10.42 B-1,196.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
-S$39.27 Million-95.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$84.45 M-108.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-S$0.35 Billion-63.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
S$5.57 M-100.59%๐Ÿ‡บ๐Ÿ‡ธ USA